Stock listing

A3DMBV Stock Price, News, Filings & Events — H. Lundbeck A/s Class A

Selected listing: A3DMBV · LS · EUR · DE

This page tracks H. Lundbeck A/s Class A's A3DMBV:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3DMBV:LS. A3DMBV:LS is the stock-level entry point for investors researching H. Lundbeck A/s Class A, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. H. Lundbeck A/s Class A is a public company based in Denmark, focusing on pharmaceuticals, particularly in the field of mental health. The company has a market capitalization of approximately 5.07 billion USD. Lundbeck is known for its commitment to developing innovative treatments for psychiatric and neurological disorders.

A3DMBV:LSEURDEUpdated August 28, 2026
H. Lundbeck A/s Class A logo
Ticker
A3DMBV:LS
Asset type
Stock
Market cap
$5.17B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
LS
Currency
EUR

H. Lundbeck A/s Class A A3DMBV:LS stock context

This page tracks H. Lundbeck A/s Class A's A3DMBV:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3DMBV:LS. A3DMBV:LS is the stock-level entry point for investors researching H. Lundbeck A/s Class A, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. H. Lundbeck A/s Class A is a public company based in Denmark, focusing on pharmaceuticals, particularly in the field of mental health. The company has a market capitalization of approximately 5.07 billion USD. Lundbeck is known for its commitment to developing innovative treatments for psychiatric and neurological disorders.

Latest news from H. Lundbeck A/s Class A

All H. Lundbeck A/s Class A news →

H. Lundbeck A/s Class A earnings calls

Research H. Lundbeck A/s Class A

Alternate listings